Emotional Intelligence Ventures and Mycotopia enter a Definitive Agreement on $382M merger transaction

Ei Ventures has executed a definitive agreement with Mycotopia bringing the two entities together under PSLY.com as the companies move forward with their plan of uplisting to the NASDAQ stock exchange.

Ei shareholders will receive shares in PSLY.com based upon a valuation of $360 Million at the close of the transaction. Mycotopia shareholders will receive shares in PSLY.com based upon a valuation of more than $23 million at the close of the transaction.

Become a psychedelic insider!

With a free Blossom membership you will always be in the know.

📰 Weekly newsletter about the psychedelic research

✔️ Unlimited access to our database and original articles

🖊️ Add (private) notes and comments to each page

Make an account
Category Press Release
Published in GlobeNewswire

Companies Featured

EI.Ventures
EI.Ventures is a subsidiary of Orthogonal Thinker that is currently raising $50 million. Though scant on details, the company is developing Psilly (whole-plant botanical psilocybin-based formulation) and has (presumably) launched a consumer non-psychedelic mushroom brand 'Mana'.

Mycotopia Therapies
Mycotopia are researching and developing psychedelic therapies for mental disorders including; anxiety, depression, bipolar disorders, PTSD, ADHD, autism and addictions.

0 Comments
Inline Feedbacks
View all comments